Program
A full day of discussion on drug target discovery, validation, and repurposing.
Sessions
Session times will be announced here.
-
Opening
Welcome and opening remarks
The two departments will open the symposium and frame the questions that connect the day’s sessions, from choosing targets to deciding what evidence would support developing a therapy.
-
Keynote
Keynote address
An invited talk on how AI and human genetics can inform therapeutic discovery, and how researchers can judge which predictions are worth pursuing.
-
Trainee discussion30 minutes
Keynote discussion
A separate, informal Q&A for trainees to talk with the keynote speaker about the role of AI in biomedical research.
-
Panel 1
The Inside Track
Drug discovery resources at Mount Sinai
What support is available to researchers moving a genetic finding toward drug discovery? This panel will discuss Mount Sinai resources, the kinds of projects they can help with, and how researchers can begin working with them.
-
Panel 2
Show Me the Variant
Identifying drug targets
How do researchers decide which genetic findings point to targets worth testing? This panel will look at what the Genetic Priority Score and other tools can tell researchers about a potential target, how AI can help interpret the evidence, and when more evidence is needed.
-
Panel 3
The Burden of Proof
Choosing models and experiments
What makes an experiment a good test of a predicted drug target? Panelists will discuss how to choose models and assays, interpret results across systems, and judge when the evidence supports taking a target further.
-
Panel 4
The Second Indication
Drug repurposing
When might an existing medicine be useful for a different disease? This panel will examine how genetic evidence and pharmacology can suggest new uses and what researchers would need to test before pursuing them.
-
Project pitches
From Pitch to Pilot
In this Shark Tank-style session, finalist teams will pitch early drug discovery projects to a panel. The panel will provide feedback and award pilot funding to the teams with the most potential to move their projects forward.
Explore the pitch session
